232 related articles for article (PubMed ID: 32870822)
1. LILRB3 (ILT5) is a myeloid cell checkpoint that elicits profound immunomodulation.
Yeboah M; Papagregoriou C; Jones DC; Chan HTC; Hu G; McPartlan JS; Schiött T; Mattson U; Mockridge CI; Tornberg UC; Hambe B; Ljungars A; Mattsson M; Tews I; Glennie MJ; Thirdborough SM; Trowsdale J; Frendeus B; Chen J; Cragg MS; Roghanian A
JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32870822
[TBL] [Abstract][Full Text] [Related]
2. The Orphan Immune Receptor LILRB3 Modulates Fc Receptor-Mediated Functions of Neutrophils.
Zhao Y; van Woudenbergh E; Zhu J; Heck AJR; van Kessel KPM; de Haas CJC; Aerts PC; van Strijp JAG; McCarthy AJ
J Immunol; 2020 Feb; 204(4):954-966. PubMed ID: 31915259
[TBL] [Abstract][Full Text] [Related]
3. Copy number and nucleotide variation of the LILR family of myelomonocytic cell activating and inhibitory receptors.
López-Álvarez MR; Jones DC; Jiang W; Traherne JA; Trowsdale J
Immunogenetics; 2014 Feb; 66(2):73-83. PubMed ID: 24257760
[TBL] [Abstract][Full Text] [Related]
4. LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development.
Huang R; Liu X; Kim J; Deng H; Deng M; Gui X; Chen H; Wu G; Xiong W; Xie J; Lewis C; Homsi J; Yang X; Zhang C; He Y; Lou Q; Smith C; John S; Zhang N; An Z; Zhang CC
Cancer Immunol Res; 2024 Mar; 12(3):350-362. PubMed ID: 38113030
[TBL] [Abstract][Full Text] [Related]
5. LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy.
Mai S; Hodges A; Chen HM; Zhang J; Wang YL; Liu Y; Nakatsu F; Wang X; Fang J; Xu Y; Davidov V; Kang K; Pingali SR; Ganguly S; Suzuki M; Konopleva M; Prinzing B; Zu Y; Gottschalk S; Lu Y; Chen SH; Pan PY
Cancer Res; 2023 Dec; 83(24):4047-4062. PubMed ID: 38098451
[TBL] [Abstract][Full Text] [Related]
6. Diversity of the human LILRB3/A6 locus encoding a myeloid inhibitory and activating receptor pair.
Bashirova AA; Apps R; Vince N; Mochalova Y; Yu XG; Carrington M
Immunogenetics; 2014 Jan; 66(1):1-8. PubMed ID: 24096970
[TBL] [Abstract][Full Text] [Related]
7. Allele-specific recognition by LILRB3 and LILRA6 of a cytokeratin 8-associated ligand on necrotic glandular epithelial cells.
Jones DC; Hewitt CR; López-Álvarez MR; Jahnke M; Russell AI; Radjabova V; Trowsdale AR; Trowsdale J
Oncotarget; 2016 Mar; 7(13):15618-31. PubMed ID: 26769854
[TBL] [Abstract][Full Text] [Related]
8. LILRB3 supports acute myeloid leukemia development and regulates T-cell antitumor immune responses through the TRAF2-cFLIP-NF-κB signaling axis.
Wu G; Xu Y; Schultz RD; Chen H; Xie J; Deng M; Liu X; Gui X; John S; Lu Z; Arase H; Zhang N; An Z; Zhang CC
Nat Cancer; 2021 Nov; 2(11):1170-1184. PubMed ID: 35122056
[TBL] [Abstract][Full Text] [Related]
9. Characterization of LILRB3 and LILRA6 allelic variants in the Japanese population.
Hirayasu K; Sun J; Hasegawa G; Hashikawa Y; Hosomichi K; Tajima A; Tokunaga K; Ohashi J; Hanayama R
J Hum Genet; 2021 Jul; 66(7):739-748. PubMed ID: 33526815
[TBL] [Abstract][Full Text] [Related]
10. Distinct frequency patterns of LILRB3 and LILRA6 allelic variants in Europeans.
Bashirova AA; Kasprzak W; O'hUigin C; Carrington M
Immunogenetics; 2023 Jun; 75(3):263-267. PubMed ID: 36449053
[TBL] [Abstract][Full Text] [Related]
11. Chicken immunoregulatory Ig-like receptor families: an overview and expression details on ggTREM-A1.
Viertlboeck BC; Hanczaruk MA; Amann B; Bader SR; Schmitt R; Sperling B; Schwarz SC; Schmahl W; Deeg CA; Göbel TW
Dev Comp Immunol; 2013 Nov; 41(3):403-12. PubMed ID: 23648646
[TBL] [Abstract][Full Text] [Related]
12. Comparative assessment of the recognition of domain-specific CD163 monoclonal antibodies in human monocytes explains wide discrepancy in reported levels of cellular surface CD163 expression.
Maniecki MB; Etzerodt A; Moestrup SK; Møller HJ; Graversen JH
Immunobiology; 2011 Aug; 216(8):882-90. PubMed ID: 21458881
[TBL] [Abstract][Full Text] [Related]
13. Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts.
Zhang W; Liang S; Wu J; Horuzsko A
Transplantation; 2008 Oct; 86(8):1125-34. PubMed ID: 18946352
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of leukocyte Ig-like receptor LILRB4 (ILT3/LIR-5/CD85k): a myeloid inhibitory receptor involved in immune tolerance.
Cheng H; Mohammed F; Nam G; Chen Y; Qi J; Garner LI; Allen RL; Yan J; Willcox BE; Gao GF
J Biol Chem; 2011 May; 286(20):18013-25. PubMed ID: 21454581
[TBL] [Abstract][Full Text] [Related]
15. Leukocyte Immunoglobulin-Like Receptors (LILRs) on Human Neutrophils: Modulators of Infection and Immunity.
Lewis Marffy AL; McCarthy AJ
Front Immunol; 2020; 11():857. PubMed ID: 32477348
[TBL] [Abstract][Full Text] [Related]
16. LILRB receptor-mediated regulation of myeloid cell maturation and function.
van der Touw W; Chen HM; Pan PY; Chen SH
Cancer Immunol Immunother; 2017 Aug; 66(8):1079-1087. PubMed ID: 28638976
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte Ig-Like receptor B1 restrains dendritic cell function through increased expression of the NF-κB regulator ABIN1/TNIP1.
Khanolkar RC; Kalogeropoulos M; Lawrie A; Roghanian A; Vickers MA; Young NT
J Leukoc Biol; 2016 Oct; 100(4):737-746. PubMed ID: 27129285
[TBL] [Abstract][Full Text] [Related]
18. The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions.
Saverino D; Fabbi M; Ghiotto F; Merlo A; Bruno S; Zarcone D; Tenca C; Tiso M; Santoro G; Anastasi G; Cosman D; Grossi CE; Ciccone E
J Immunol; 2000 Oct; 165(7):3742-55. PubMed ID: 11034379
[TBL] [Abstract][Full Text] [Related]
19. Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures.
Allen RL; Raine T; Haude A; Trowsdale J; Wilson MJ
J Immunol; 2001 Nov; 167(10):5543-7. PubMed ID: 11698424
[TBL] [Abstract][Full Text] [Related]
20. Characterization and epitope mapping of two monoclonal antibodies against human CD99.
Gil MC; Lee MH; Seo JI; Choi YL; Kim MK; Jung KC; Park SH; Kim TJ
Exp Mol Med; 2002 Dec; 34(6):411-8. PubMed ID: 12526082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
